Dr. Christopher N. Compton, MD

Dr. Compton practices at Bec Oracle LLC in Tucson, Arizona.

Dr. Compton's NPI, 1790780880, was assigned on June 16, 2005. Dr. Compton graduated from Wayne State University School Of Medicine in 1998. Dr. Compton holds Arizona license 34117.

Dr. Compton's primary practice is Bec Oracle LLC, at 6377 E Tanque Verde Rd, Tucson, AZ 85715 in Pima County. The practice phone is (520) 372-2374.

Dr. Compton's primary practice is Bec Oracle LLC in Tucson, Arizona. Dr. Compton is also affiliated with Tucson Medical Center. The medical group on file is Tucson Medical Center. Dmand AI also links Dr. Compton to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Compton practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Compton's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Compton is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Compton's licenses on file in 4 states: Arizona, Missouri, Pennsylvania and Ohio.

Dmand AI lists amputation, aortic atherosclerois, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), leg revascularization, lymphedema and peripheral vascular disease among the conditions Dr. Compton treats.

CMS data shows 1,246 Medicare services from Dr. Compton across 16 procedure codes in 2024, for 650 Medicare patients. Medicare paid $137,186 for them.

CMS counts 650 Medicare patients who saw Dr. Compton in 2024. The largest group is 75 to 84, with 285 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Compton's median patient age at 74, with 52% women.

In 2024, Dr. Compton wrote 322 Medicare Part D claims for 146 patients. 61% of them were for generic drugs. CMS names the drug for 231 of them, across 7 drugs with 11 or more claims each, at $123,403 in total drug cost. In 2023, CMS named 302 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 54 out of 100 for Dr. Compton for performance year 2024, reported as part of a group. Dr. Compton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 29 procedures of leg revascularization (restoring blood flow) by Dr. Compton, more than 88% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Compton. Dr. Compton's most frequent co-authors are Ellen D. Dillavou, MD and Michel S. Makaroun, MD.

CMS Open Payments shows 386 general payments to Dr. Compton from 49 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 44% of the total. Tactile Systems Technology Inc paid the most, $20,519.

Dmand AI lists 1 award for Dr. Compton, most recently CMS Stage 1 EHR in 2013.

Dr. Compton graduated from Wayne State University School Of Medicine in 1998.

Dr. Compton is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.